UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer

British journal of cancer, 2012-08, Vol.107 (5), p.793-799

2012

Volltextzugriff (PDF)

Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up

Acta Paediatrica, 2012-01, Vol.101 (1), p.e42-e47

2012

Volltextzugriff (PDF)

Non-neuronopathic Gaucher disease due to saposin C deficiency

Clinical genetics, 2007-12, Vol.72 (6), p.538-542

2007

Volltextzugriff (PDF)

Female Hunter syndrome caused by a single mutation and familial XCI skewing: implications for other X-linked disorders

Clinical genetics, 2011-11, Vol.80 (5), p.459-465

2011

Volltextzugriff (PDF)

Assessment of Relations between Clinical Outcome of Ischemic Stroke and Activity of Inflammatory Processes in the Acute Phase Based on Examination of Selected Parameters

European neurology, 2005-01, Vol.53 (4), p.188-193

2005

Volltextzugriff (PDF)

Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland

Clinical genetics, 2005-07, Vol.68 (1), p.48-54

2005

Volltextzugriff (PDF)

5084 POSTER Receptor Conversion in Breast Cancer Brain Metastases (BM)

European journal of cancer (1990), 2011, Vol.47, p.S355-S355

2011

Volltextzugriff (PDF)

Enzyme replacement therapy in type III Gaucher disease

Journal of inherited metabolic disease, 1999-04, Vol.22 (2), p.203-204

1999

Volltextzugriff (PDF)

Globoid cell leukodystrophy of adult. A first case in Poland

Neurologia i neurochirurgia polska, 2013-05, Vol.47 (3), p.278

2013

Volltextzugriff (PDF)

High prevalence of I179S mutation in patients with late-onset metachromatic leukodystrophy

Clinical genetics, 2002-05, Vol.61 (5), p.389-390

2002

Volltextzugriff (PDF)

Globoid cell leukodystrophy of adult. A first case in Poland

Neurologia i neurochirurgia polska, 2013-05, Vol.47 (3), p.278-282

2013

Volltextzugriff (PDF)

Abstract P2-10-31: Correlation of quantitative p95HER2 and total HER2 levels with clinical outcomes in a combined analysis of two cohorts of trastuzumab-treated metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-10-31

2012

Volltextzugriff (PDF)

Abstract P2-05-21: Predictive value of quantitative HER2 and HER3 levels combined with downstream signaling markers in HER2-positive advanced breast cancer patients treated with lapatinib

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-21

2017

Volltextzugriff (PDF)

Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases

Neuro-oncology (Charlottesville, Va.), 2015-09, Vol.17 (9), p.1241-1249

2015

Volltextzugriff (PDF)

Continuation of trastuzumab-based therapy beyond disease progression in metastatic breast cancer patients – a retrospective one center analysis

European journal of cancer supplements, 2008, Vol.6 (7), p.221-221

2008

Volltextzugriff (PDF)

Correlation between quantitative HER2 protein level and the risk of brain metastasis (BM) in patients (pts) with metastatic breast cancer (MBC) treated with trastuzumab-containing therapy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1030-1030

2010

Volltextzugriff (PDF)

The neuronal cell adhesion molecule L1CAM as a therapeutic targe in breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21138-e21138

2011

Volltextzugriff (PDF)

Quantitative measurements of p95HER2 (p95) and total HER2 (H2T) protein expression in patients with trastuzumab-treated, metastatic breast cancer (MBC): Independent confirmation of clinical cutoffs

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.586-586

2011

Volltextzugriff (PDF)

Mutations c.459 + 1G > A and p.P426L in the ARSA gene: Prevalence in metachromatic leukodystrophy patients from European countries

Molecular genetics and metabolism, 2005-11, Vol.86 (3), p.353-359

2005

Volltextzugriff (PDF)

Serum hyaluronidase aberrations in metabolic and morphogenetic disorders

Glycoconjugate journal, 2005-11, Vol.22 (7-9), p.395-400

2005

Volltextzugriff (PDF)

Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex

Human molecular genetics, 2000-04, Vol.9 (7), p.1075-1085

2000

Volltextzugriff (PDF)

Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human α-L-iduronidase (laronidase, Aldurazyme)

American journal of medical genetics. Part A, 2005-12, Vol.139A (3), p.199-203

2005

Volltextzugriff (PDF)

Abstract P6-11-07: Quantitative p95HER2 levels in primary breast cancers and in matched brain metastases

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P6-P6-11-07

2013

Volltextzugriff (PDF)

Prediction of brain relapse by gene expression analysis in HER2-positive metastatic breast cancer patients

European journal of cancer supplements, 2008, Vol.6 (7), p.193-193

2008

Volltextzugriff (PDF)

Hyaluronidase in human somatic tissues and urine: polymorphism and the activity in diseases

Acta biochimica polonica, 1995, Vol.42 (1), p.31-33

1995

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(86)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(61)
Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Male
(28)
Female
(27)
Adult
(24)
Child
(19)
Biological And Medical Sciences
(18)
Adolescent
(17)
Medical Sciences
(16)
Genetics & Heredity
(15)
Child, Preschool
(12)
Errors Of Metabolism
(12)
Metabolic Diseases
(12)
Middle Aged
(10)
Infant
(9)
Leukodystrophy, Metachromatic - Genetics
(9)
Mutation
(9)
Animals
(8)
Aged
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer

Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up

Non-neuronopathic Gaucher disease due to saposin C deficiency

Female Hunter syndrome caused by a single mutation and familial XCI skewing: implications for other X-linked disorders

Assessment of Relations between Clinical Outcome of Ischemic Stroke and Activity of Inflammatory Processes in the Acute Phase Based on Examination of Selected Parameters

Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland

5084 POSTER Receptor Conversion in Breast Cancer Brain Metastases (BM)

Enzyme replacement therapy in type III Gaucher disease

Globoid cell leukodystrophy of adult. A first case in Poland

High prevalence of I179S mutation in patients with late-onset metachromatic leukodystrophy

Globoid cell leukodystrophy of adult. A first case in Poland

Abstract P2-10-31: Correlation of quantitative p95HER2 and total HER2 levels with clinical outcomes in a combined analysis of two cohorts of trastuzumab-treated metastatic breast cancer patients

Abstract P2-05-21: Predictive value of quantitative HER2 and HER3 levels combined with downstream signaling markers in HER2-positive advanced breast cancer patients treated with lapatinib

Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases

Continuation of trastuzumab-based therapy beyond disease progression in metastatic breast cancer patients – a retrospective one center analysis

Correlation between quantitative HER2 protein level and the risk of brain metastasis (BM) in patients (pts) with metastatic breast cancer (MBC) treated with trastuzumab-containing therapy

The neuronal cell adhesion molecule L1CAM as a therapeutic targe in breast cancer

Quantitative measurements of p95HER2 (p95) and total HER2 (H2T) protein expression in patients with trastuzumab-treated, metastatic breast cancer (MBC): Independent confirmation of clinical cutoffs

Mutations c.459 + 1G > A and p.P426L in the ARSA gene: Prevalence in metachromatic leukodystrophy patients from European countries

Serum hyaluronidase aberrations in metabolic and morphogenetic disorders

Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex

Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human α-L-iduronidase (laronidase, Aldurazyme)

Abstract P6-11-07: Quantitative p95HER2 levels in primary breast cancers and in matched brain metastases

Prediction of brain relapse by gene expression analysis in HER2-positive metastatic breast cancer patients

Hyaluronidase in human somatic tissues and urine: polymorphism and the activity in diseases

Suchergebnisse filtern